Connect with us
[bsa_pro_ad_space id=12]

Addictions

Illicit drug use still tolerated in some B.C. hospital rooms, says recent patient

Published

6 months ago

9 minute read

Illustration courtesy of Midjourney

News release from Break The Needle

Vancouverite Mark Budworth says he was exposed to illicit drug smoke while recovering from an ankle replacement at St. Paul’s Hospital.

Two months ago, nurses across British Columbia said that the provincial government had allowed addicts to openly smoke illicit drugs, such as fentanyl and meth, in hospital rooms to the detriment of frontline workers and other patients. The province subsequently committed to banning the practice – but testimony from a recently hospitalized patient suggests that, at least in some hospitals, this crackdown may not have been serious.

Mark Budworth is a semi-retired Vancouverite in his early 60s who received a full ankle replacement at St. Paul’s Hospital, one of the province’s preeminent medical institutions, in mid-May. In a recent phone interview, he told Break The Needle that, during his four day stay, he was exposed to illicit drug use that was tolerated by staff and made him feel unsafe.

Though only one story, his account fits into a broader picture of rampant fentanyl trafficking and public disorder that has been bleeding into the province’s healthcare system, all to the seeming indifference of provincial officials.

The problems allegedly began after his surgery when he was wheeled into his hospital room, which was shared with another patient who seemed around 30 years old. “There was a strong smell of smoke. And it didn’t smell like tobacco smoke. It smelled like drugs,” said Budworth, who claimed that the hospital porters transporting him commented on the smell but were largely indifferent to it. To his knowledge, no attempts were made by staff to do anything about the apparent illicit drug use.

The next day, Budworth had a friend visit him. He said that the hospital roommate introduced himself to them and was in a “euphoric” and “confused” state, which made them uncomfortable and led the friend to later speculate that the roommate may have been high on meth. After the friend departed, the roommate allegedly left the room and, upon returning, told Budworth that he had bought $200 of fentanyl.

Subscribe to our newsletter to get our latest news and analysis – 

or donate to our investigative journalism fund.

Budworth said that, around midnight that night, he awoke and realized that his roommate, who sounded very intoxicated, was in the middle of an “aggressive” conversation with a female visitor, which sounded “a little scary.” He said the smell of illicit drug smoke lingered in the air and that he called the nurses who, in turn, summoned security guards. As the woman was being removed, security told her to pull her pants up from around her knees, he said.

The alleged incident left Budworth feeling unsafe, as he worried that he might face retaliation from his roommate. The hospital’s nurses refused to relocate him to a new room at first, but eventually relented after he persistently emphasized his safety concerns, he said.

In his second room, his new roommate was a homeless man who would often leave to smoke cigarettes and marijuana, he said. This new roommate allegedly told Budworth that the hospital’s fourth floor rooftop courtyard is an open drug market where people regularly fight and smoke fentanyl.

Budworth said that, throughout the rest of his stay, he spoke with several hospital staff and, though they were “wonderful,” his conversations with them suggested that illicit drug use was tolerated in the building. “The staff didn’t seem to think it was a big deal. It was normal,” he said.

He claimed to have spoken with four nurses, some of whom suggested that illicit drug use among patients was making their jobs difficult. “They’re people dealing with unlimited problems with limited resources,” he said.

After Budworth was discharged from the hospital, he wrote a letter to Health Minister Adrian Dix explaining his concerns, which he then forwarded to Break The Needle. “I’ve read a lot of articles about the nurses complaining. I hadn’t yet read an article about a patient complaining – patients’ experience. And that’s why I thought I should go on record,” he explained over the phone.

The conditions Budworth recalled at St. Paul’s were largely consistent with what was described in a news report published by Glacier Media Group in early April, before the province cracked down on open drug use in hospitals. In that report, a nurse who worked at the hospital told journalist Rob Shaw, “You can barely walk into some of the rooms, there’s needles and broken crack pipes and dirty food all over the floor.”

“Absolutely there are people throughout that hospital who are dealing and using everywhere,” said the nurse at the time. “We know they are drug dealers, and yet they come and go.”

Budworth’s testimony raises concerns about whether the provincial government’s attempts to control illicit drug use in hospitals have, at least in some instances, been unsuccessful.

In an emailed response sent to Break The Needle on May 30, a media representative of St. Paul’s stated that illicit drug use is not permitted anywhere in the hospital, except for an outdoor overdose prevention site (OPS) on the rooftop courtyard, which she said had received approximately 600 unique visits in the preceding two weeks.

The representative wrote that drug trafficking has “never been permitted” anywhere at the hospital, including the OPS. “Security has increased at our sites to support clinical teams as they respond to problematic behaviours, aggression, drug use, and illicit drug dealing in hospitals.”

But apparently those policies neither protected Budworth nor safeguarded his right to a dignified hospital stay free from illicit drugs and intimidating behaviour.

He blamed the province’s failed drug decriminalization experiment, which was recently scaled back by the BC NDP, and said that the decriminalization movement made him feel “uncomfortable” because, “We’re seeing people smoking fentanyl on the streets already… which is easy to walk away from when you’re mobile, but when you’re in a hospital bed and it’s happening in your room, it’s a little too close.”

“I was gonna vote NDP. I think the provincial government’s pretty good, but, with this experience, they lost my vote on this one… I don’t think that our current government and Victoria is really considering all the stakeholders on this issue,” he said.

[This article has been co-published with The Bureau, a Canadian media outlet that tackles corruption and foreign influence campaigns through investigative journalism. Subscribe to their work to get the latest updates on how organized crime influences the Canadian drug trade.]

Break The Needle.

Our content is always free – but if you want to help us commission more high-quality journalism, consider getting a voluntary paid subscription.

 

Related Topics:

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

More from this author
Alberta / 48 mins ago

Alberta’s fiscal update projects budget surplus, but fiscal fortunes could quickly turn

Business / 4 hours ago

Trump’s government efficiency department plans to cut $500 Billion in unauthorized expenditures, including funding for Planned Parenthood

Alberta / 7 hours ago

Alberta government announces review of Trudeau’s euthanasia regime

Addictions

BC Addictions Expert Questions Ties Between Safer Supply Advocates and For-Profit Companies

Published on November 20, 2024

By

By Liam Hunt

Canada’s safer supply programs are “selling people down the river,” says a leading medical expert in British Columbia. Dr. Julian Somers, director of the Centre for Applied Research in Mental Health and Addiction at Simon Fraser University, says that despite the thin evidence in support of these experimental programs, the BC government has aggressively expanded them—and retaliated against dissenting researchers.

Somers also, controversially, raises questions about doctors and former health officials who appear to have gravitated toward businesses involved in these programs. He notes that these connections warrant closer scrutiny to ensure public policies remain free from undue industry influence.

Safer supply programs claim to reduce overdoses and deaths by distributing free addictive drugs—typically 8-milligram tablets of hydromorphone, an opioid as potent as heroin—to dissuade addicts from accessing riskier street substances. Yet, a growing number of doctors say these programs are deeply misguided—and widely defrauded.

Ultimately, Somers argues, safer supply is exacerbating the country’s addiction crisis.

Somers opposed safer supply at its inception and openly criticized its nationwide expansion in 2020. He believes these programs perpetuate drug use and societal disconnection and fail to encourage users to make the mental and social changes needed to beat addiction. Worse yet, the safer supply movement seems rife with double standards that devalue the lives of poorer drug users. While working professionals are provided generous supports that prioritize recovery, disadvantaged Canadians are given “ineffective yet profitable” interventions, such as safer supply, that “convey no expectation that stopping substance use or overcoming addiction is a desirable or important goal.”

To better understand addiction, Somers created the Inter-Ministry Evaluation Database (IMED) in 2004, which, for the first time in BC’s history, connected disparate information—i.e. hospitalizations, incarceration rates—about vulnerable populations.

Throughout its existence, health experts used IMED’s data to create dozens of research projects and papers. It allowed Somers to conduct a multi-million-dollar randomized control trial (the “Vancouver at Home” study) that showed that scattering vulnerable people into regular apartments throughout the city, rather than warehousing them in a few buildings, leads to better outcomes at no additional cost.

In early 2021, Somers presented recommendations drawn from his analysis of the IMED to several leading officials in the B.C. government. He says that these officials gave a frosty reception to his ideas, which prioritized employment, rehabilitation, and social integration over easy access to drugs. Shortly afterwards, the government ordered him to immediately and permanently delete the IMED’s ministerial data.

Somers describes the order as a “devastating act of retaliation” and says that losing access to the IMED effectively ended his career as a researcher. “My lab can no longer do the research we were doing,” he noted, adding that public funding now goes exclusively toward projects sympathetic to safer supply. The B.C. government has since denied that its order was politically motivated.

In early 2022, the government of Alberta commissioned a team of researchers, led by Somers, to investigate the evidence base behind safer supply. They found that there was no empirical proof that the experiment works, and that harm reduction researchers often advocated for safer supply within their studies even if their data did not support such recommendations.

Somers says that, after these findings were published, his team was subjected to a smear campaign that was partially organized by the British Columbia Centre on Substance Use (BCCSU), a powerful pro-safer supply research organization with close ties to the B.C. government. The BCCSU has been instrumental in the expansion of safer supply and has produced studies and protocols in support of it, sometimes at the behest of the provincial government.

Somers is also concerned about the connections between some of safer supply’s key proponents and for-profit drug companies.

He notes that the BCCSU’s founding executive director, Dr. Evan Wood, became Chief Medical Officer at Numinus Wellness, a publicly traded psychedelic company, in 2020. Similarly, Dr. Perry Kendall, who also served as a BCCSU executive director, went on to found Fair Price Pharma, a now-defunct for-profit company that specializes in providing pharmaceutical heroin to high-risk drug users, the following year.

While these connections are not necessarily unethical, they do raise important questions about whether there is enough industry regulation to minimize potential conflicts of interest, whether they be real or perceived.

The BCCSU was also recently criticized in an editorial by Canadian Affairs, which noted that the organization had received funding from companies such as Shoppers Drug Mart and Tilray (a cannabis company). The editorial argued that influential addiction research organizations should not receive drug industry funding and reported that Alberta founded its own counterpart to the BCCSU in August, known as the Canadian Centre of Recovery Excellence, which is legally prohibited from accepting such sponsorships.

Already, private interests are betting on the likely expansion of safer supply programs. For instance, Safe Supply Streaming Co., a publicly traded venture capital firm, has advertised to potential investors that B.C.’s safer supply system could create a multi-billion-dollar annual market.

Somers believes that Canada needs more transparency regarding how for-profit companies may be directly or indirectly influencing policy makers: “We need to know exactly, to the dollar, how much of [harm reduction researchers’] operating budget is flowing from industry sources.”

Editor’s note: This story is published in syndication with Break The Needle and Western Standard.

The Bureau is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Dr. Julian M. Somers is director of the Centre for Applied Research in Mental Health and Addiction at Simon Fraser University. He was Director of the UBC Psychology Clinic, and past president of the BC Psychological Association. Liam Hunt is a contributing author to the Centre For Responsible Drug Policy in partnership with the Macdonald-Laurier Institute.

Continue Reading

Addictions

Ottawa “safer supply” clinic criticized by distraught mother

Published on November 12, 2024

By

By Alexandra Keeler

An Ottawa mother, who lost her daughter to addiction, is frustrated by Recovery Care’s failure to help her opioid-addicted son

Masha Krupp has already lost one child to an overdose and fears she could lose another.

In 2020, her 47-year-old daughter Larisa died from methadone toxicity just 12 days into an opioid addiction treatment program. The program is run by Recovery Care, an Ottawa-based harm reduction clinic with five locations across the city, which aims to stabilize drug users and eventually wean them off more potent drugs.

Krupp says she is skeptical about the effectiveness of the support and counseling services that Recovery Care claims to provide and believes the clinic was negligent in her daughter’s case.

On Oct. 22, the Ottawa mother testified before the House of Commons Standing Committee on Health, which is studying Canada’s opioid epidemic.

In her testimony, Krupp said her daughter was prescribed 30mg of methadone — 50 per cent more than the recommended induction dose — and was not given an opiate tolerance test before starting the program. Larisa received treatment at the Bells Corners Recovery Care location.

Krupp’s 30-year-old son, whom Canadian Affairs agreed not to name, has been a patient at Recovery Care’s ByWard Market location since 2021, where he receives a combination of methadone and hydromorphone, another prescription drug administered through the treatment program.

“Three years later, my son is still using fentanyl, crack cocaine and methadone, despite being with Dr. [Charles] Breau and with Recovery Care for over three years,” Krupp testified.

“About four weeks ago, I had to call 9-1-1 because he was overdosing,” Krupp told Canadian Affairs in an interview. “This is on the safer supply program … three years in, I should not be calling 9-1-1.”

Open diversion

Founded in 2018, Recovery Care is a partner in the Safer Supply Ottawa initiative. The initiative, which is led by Ottawa Public Health and managed by the nonprofit Pathways to Recovery, provides prescription pharmaceutical opioids to individuals who are at high risk of overdose.

Pathways to Recovery works with a network of service providers throughout the city — including Recovery Care — to administer safer supply.

Krupp says she supports the concept of safer supply, but believes it needs to be administered differently.

“You can’t give addicts 28 pills and say ‘Oh here you go,’” she said in her testimony. “They sell for three dollars a pop on the street,” she said, referring to the practice of some individuals selling their prescribed medications to fund purchases of more intense street drugs like heroin and fentanyl.

Krupp says she sees her son — and other patients of the program — openly divert their prescribed medications outside of the Recovery Care clinic in ByWard Market, where she parks to wait for him.

“[B]ecause there’s no treatment attached to [my son’s safer supply], it’s just the doctor gives him all these pills, he diverts them, gets the drugs he needs, and he’s still an addict,” Krupp said in her testimony.

Donna Sarrazin, chief executive of Recovery Care, told Canadian Affairs that Recovery Care has measures to address diversion, including security cameras and onsite security staff.

“Patients are educated at intake and ongoing that diversion is not permitted and that they could be removed from the program,” she said in an emailed statement.

“Recovery Care works to understand diversion and has continued to progress programs and actions to address the issues. Concerns expressed by the community and our teams are taken seriously,” she said.

Krupp says she has communicated her concerns about her son reselling his prescribed medications to his doctor, Dr. Charles Breau, both in-person and through faxed letters. “I never hear back from the doctor. Never,” she said.

Krupp also said in her testimony that police have spoken to her son about his diversion.

Breau did not respond to inquiries made to his clinical teams at Recovery Care or Montfort Hospital, a teaching hospital affiliated with the University of Ottawa.

Sarrazin said Breau is not able to comment on patient or family care.

In Krupp’s view, the safer supply program would be more successful if drug users were required to take prescribed medications under supervision.

“If he was receiving his hydromorphone under witnessed dosage and there was a treatment plan attached to it, I believe it would be successful,” she said.

Dr. Eileen de Villa, the City of Toronto’s medical officer of health, reinforced this point at the Oct. 22 Health Committee meeting. She said Toronto Public Health’s injectable opioid agonist therapy program — which combines observed administration with a treatment plan — has seen “incredible results.”

De Villa shared a case of a pregnant client who entered the program. “She went on to have a successful pregnancy, a healthy baby, has actually successfully completed the treatment, and is now housed and has even gained custody of her other children,” she said.

Subscribe for free to get BTN’s latest news and analysis, or donate to our journalism fund.

‘An affront to me’

Krupp also says Recovery Care fails to deliver on its promise of supporting patients’ mental health needs. Recovery Care’s website says its clinics offer “mental health programs which are essential to every treatment plan.”

Krupp and her son’s father have both requested a clear treatment plan and consistent counselling for their son. But he was started on safer supply after participating in only one virtual counselling session, she says.

She says Recovery Care has only one mental health counselor who services four of Recovery Care’s clinics. “If you’re getting $2-million-plus a year in funding, you should be able to staff each clinic with one on-site counselor five days a week,” she said.

Instead of personalized assistance, her son received “a sheaf of photocopies” offering generic services like Narcotics Anonymous and crisis helplines. “It’s almost an affront to me, as a taxpayer and a mother of an addict,” Krupp said.

Krupp says that, following her testimony to the parliamentary committee, Breau reached out to offer her son a mental health counseling session for the first time.

Sarrazin told Canadian Affairs that patients are encouraged to request counseling at any time. “Currently there is no wait list and appointments can be booked within 1 week,” she said in her emailed statement.

Class actions

Today, Krupp is considering launching a class-action lawsuit against Health Canada and the Government of Canada, challenging both the enactment of safer supply and the loosening of methadone dispensing requirements in 2017. She believes these changes contributed to her daughter’s death in 2020.

She is also considering joining an existing class-action lawsuit in B.C., which alleges Health Canada failed to monitor the distribution of drugs provided through safer supply programs.

The Pathways to Recovery initiative received $9.69-million in funding from Health Canada from July 2020 to March 2025. In June 2023, Health Canada allocated an additional $1.9 million to expand Ottawa’s safer supply program across five sites and improve access to practitioners, mental health support, housing and other services.

“I want to see that money being put to a recovery based treatment, not simply people going in and out and getting their medications and just creating this new sub-layer of addicts,” Krupp said.

This article was produced through the Breaking Needles Fellowship Program, which provided a grant to Canadian Affairs, a digital media outlet, to fund journalism exploring addiction and crime in Canada. Articles produced through the Fellowship are co-published by Break The Needle and Canadian Affairs.

Subscribe for free to get BTN’s latest news and analysis, or donate to our journalism fund.

Continue Reading

Trending

X